CTLA-4 Blockade: Autoimmunity As Treatment-Reference-Cited by-同舟云学术

CTLA-4 Blockade: Autoimmunity As Treatment

Published:2005-12-10 Issue:35 Volume:23 Page:8926-8928
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Kapadia Dilnawaz¹,Fong Lawrence¹

Affiliation:

1. Department of Medicine, Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.07.012

Reference30 articles.

1. Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor Occupancy

2. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

3. Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation

4. Martin PJ, Ledbetter JA, Morishita Y, et al: A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J Immunol 136:3282,1986-3287,

5. Jenkins MK, Taylor PS, Norton SD, et al: CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 147:2461,1991-2466,

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilars in Prostate Cancer;Biosimilars for Cancer Treatment;2024

2. Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma;American Journal of Otolaryngology;2023-11

3. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines;Seminars in Cancer Biology;2023-01

4. CCL22 Signaling in the Tumor Environment;Advances in Experimental Medicine and Biology;2020

5. Immunotoxicology of Biopharmaceutics;Comprehensive Toxicology;2018